RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+34.16%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$913M
AUM Growth
+$115M
(+14%)
Cap. Flow
-$73.3M
Cap. Flow
% of AUM
-8.04%
Top 10 Holdings %
Top 10 Hldgs %
28.56%
Holding
108
New
15
Increased
30
Reduced
36
Closed
14
Top Buys
| 1 |
Guardant Health
GH
|
$9.4M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$9.14M |
| 3 |
Intuitive Surgical
ISRG
|
$7.09M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.81M |
| 5 |
Cooper Companies
COO
|
$6.43M |
Top Sells
| 1 |
CVS Health
CVS
|
$12.1M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$11.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.1M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$9.05M |
Sector Composition
| 1 | Healthcare | 93.54% |
| 2 | Financials | 0.09% |
| 3 | Energy | 0.09% |
| 4 | Technology | 0.09% |
| 5 | Communication Services | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alkermes
ALKS
$4.92B
| $7.55M | 0.83% |
370,000
+150,000
| +68% | +$3.06M |
|
52
Adverum Biotechnologies
ADVM
$69M
| $7.49M | 0.82% |
65,000
+53,033
| +443% | +$6.11M |
|
|
53
Intuitive Surgical
ISRG
$158B
| $7.09M | 0.78% |
+36,000
| New | +$7.09M |
|
54
Alnylam Pharmaceuticals
ALNY
$59.3B
| $6.99M | 0.77% |
60,715
-8,285
| -12% | -$954K |
|
|
GTHX
55
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $6.96M | 0.76% |
263,400
-272,257
| -51% | -$7.2M |
|
|
BHVN
56
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.81M | 0.75% |
+125,000
| New | +$6.81M |
|
|
57
Cooper Companies
COO
$13.1B
| $6.43M | 0.7% |
+80,000
| New | +$6.43M |
|
58
Dynavax Technologies
DVAX
$1.19B
| $6.18M | 0.68% |
1,080,000
-154,335
| -13% | -$883K |
|
59
Biogen
BIIB
$20.6B
| $5.94M | 0.65% |
+20,000
| New | +$5.94M |
|
60
Sangamo Therapeutics
SGMO
$147M
| $5.86M | 0.64% |
700,000
-34,811
| -5% | -$291K |
|
61
Incyte
INCY
$17B
| $5.68M | 0.62% |
+65,000
| New | +$5.68M |
|
|
XLRN
62
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.3M | 0.58% |
100,000
+30,000
| +43% | +$1.59M |
|
|
AIMT
63
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $5.02M | 0.55% |
150,000
+799
| +0.5% | +$26.7K |
|
|
BLUE
64
DELISTED
bluebird bio
BLUE
| $5M | 0.55% |
4,400
+386
| +10% | +$439K |
|
|
ICPT
65
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.96M | 0.54% |
40,000
-7,600
| -16% | -$942K |
|
66
uniQure
QURE
$961M
| $4.3M | 0.47% |
+60,000
| New | +$4.3M |
|
67
Rigel Pharmaceuticals
RIGL
$716M
| $4.07M | 0.45% |
190,000
-10,000
| -5% | -$214K |
|
|
RVNC
68
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.06M | 0.44% |
250,000
+76,083
| +44% | +$1.23M |
|
|
NSTG
69
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.9M | 0.43% |
140,000
-2,126
| -1% | -$59.1K |
|
70
MeiraGTx Holdings
MGTX
$592M
| $3.83M | 0.42% |
+191,300
| New | +$3.83M |
|
|
SAGE
71
DELISTED
Sage Therapeutics
SAGE
| $3.61M | 0.4% |
50,000
+30,000
| +150% | +$2.17M |
|
|
MNTA
72
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.51M | 0.39% |
+178,073
| New | +$3.51M |
|
|
RDUS
73
DELISTED
Radius Health, Inc.
RDUS
| $3.43M | 0.38% |
170,000
+20,000
| +13% | +$403K |
|
|
ONC
74
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.5B
| $3.32M | 0.36% |
+20,000
| New | +$3.32M |
|
75
Abeona Therapeutics
ABEO
$358M
| $3.27M | 0.36% |
40,000
| – | – |
|